Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway

Ayesha Ismail, Heath Catoe, Sarath Dhananjayan, Zafar Nawaz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The ubiquitin-proteasome pathway (UPP) constitutes the major pathway for degradation of nuclear and cytoplasmic proteins in the eukaryotic cell. The role of the UPP in cell cycle progression and signal transduction pathways is well known, but its role in nuclear hormone receptor (NHR) functions is a surprise to many scientists. The involvement of a number of UPP components in NHR-mediated transcription suggested a possible link between these two diverse pathways. Both NHRs and their coregulators (coactivators and corepressors) are ubiquitinated and degraded by the UPP. Interestingly, the UPP enzymes and components of both the 19S and 20S proteasomes are recruited to NHR target gene promoters suggesting that the UPP could be involved in NHR transcription regulation at multiple steps. In recent years, it has been demonstrated that the role of ubiquitin can be expanded well beyond its function of acting as a death-tag for the degradation of proteins by the 26S proteasome. Keeping in mind the involvement of the UPP in a variety of cellular processes, its deregulation or malfunction has been associated with a number of human diseases including cancers. Targeting the UPP as a potential for drug discovery in the treatment of cancer and neurodegenerative disorders is just beginning. In this chapter, we will discuss the probable role of the UPP in NHR regulated gene transcription and also the possibility of targeting the UPP for drug discovery for the treatment of endocrine cancers like breast and prostate cancers.

Original languageEnglish (US)
Title of host publicationNR Coregulators and Human Diseases
PublisherWorld Scientific Publishing Co.
Pages176-207
Number of pages32
ISBN (Print)9789812819178, 9812705368, 9789812705365
DOIs
StatePublished - Jan 1 2008

Fingerprint

Proteasome Endopeptidase Complex
Cytoplasmic and Nuclear Receptors
Ubiquitin
Drug Discovery
Prostatic Neoplasms
Endocrine Gland Neoplasms
Breast Neoplasms
Co-Repressor Proteins
Eukaryotic Cells
Nuclear Proteins
Neurodegenerative Diseases
Proteolysis
Genes
Signal Transduction
Neoplasms
Cell Cycle

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ismail, A., Catoe, H., Dhananjayan, S., & Nawaz, Z. (2008). Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway. In NR Coregulators and Human Diseases (pp. 176-207). World Scientific Publishing Co.. https://doi.org/10.1142/9789812819178_0003

Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway. / Ismail, Ayesha; Catoe, Heath; Dhananjayan, Sarath; Nawaz, Zafar.

NR Coregulators and Human Diseases. World Scientific Publishing Co., 2008. p. 176-207.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ismail, A, Catoe, H, Dhananjayan, S & Nawaz, Z 2008, Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway. in NR Coregulators and Human Diseases. World Scientific Publishing Co., pp. 176-207. https://doi.org/10.1142/9789812819178_0003
Ismail A, Catoe H, Dhananjayan S, Nawaz Z. Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway. In NR Coregulators and Human Diseases. World Scientific Publishing Co. 2008. p. 176-207 https://doi.org/10.1142/9789812819178_0003
Ismail, Ayesha ; Catoe, Heath ; Dhananjayan, Sarath ; Nawaz, Zafar. / Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway. NR Coregulators and Human Diseases. World Scientific Publishing Co., 2008. pp. 176-207
@inbook{c012fe75e3f94354bc1814c43233256f,
title = "Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway",
abstract = "The ubiquitin-proteasome pathway (UPP) constitutes the major pathway for degradation of nuclear and cytoplasmic proteins in the eukaryotic cell. The role of the UPP in cell cycle progression and signal transduction pathways is well known, but its role in nuclear hormone receptor (NHR) functions is a surprise to many scientists. The involvement of a number of UPP components in NHR-mediated transcription suggested a possible link between these two diverse pathways. Both NHRs and their coregulators (coactivators and corepressors) are ubiquitinated and degraded by the UPP. Interestingly, the UPP enzymes and components of both the 19S and 20S proteasomes are recruited to NHR target gene promoters suggesting that the UPP could be involved in NHR transcription regulation at multiple steps. In recent years, it has been demonstrated that the role of ubiquitin can be expanded well beyond its function of acting as a death-tag for the degradation of proteins by the 26S proteasome. Keeping in mind the involvement of the UPP in a variety of cellular processes, its deregulation or malfunction has been associated with a number of human diseases including cancers. Targeting the UPP as a potential for drug discovery in the treatment of cancer and neurodegenerative disorders is just beginning. In this chapter, we will discuss the probable role of the UPP in NHR regulated gene transcription and also the possibility of targeting the UPP for drug discovery for the treatment of endocrine cancers like breast and prostate cancers.",
author = "Ayesha Ismail and Heath Catoe and Sarath Dhananjayan and Zafar Nawaz",
year = "2008",
month = "1",
day = "1",
doi = "10.1142/9789812819178_0003",
language = "English (US)",
isbn = "9789812819178",
pages = "176--207",
booktitle = "NR Coregulators and Human Diseases",
publisher = "World Scientific Publishing Co.",

}

TY - CHAP

T1 - Regulation of nuclear hormone receptor functions by ubiquitin-proteasome pathway

AU - Ismail, Ayesha

AU - Catoe, Heath

AU - Dhananjayan, Sarath

AU - Nawaz, Zafar

PY - 2008/1/1

Y1 - 2008/1/1

N2 - The ubiquitin-proteasome pathway (UPP) constitutes the major pathway for degradation of nuclear and cytoplasmic proteins in the eukaryotic cell. The role of the UPP in cell cycle progression and signal transduction pathways is well known, but its role in nuclear hormone receptor (NHR) functions is a surprise to many scientists. The involvement of a number of UPP components in NHR-mediated transcription suggested a possible link between these two diverse pathways. Both NHRs and their coregulators (coactivators and corepressors) are ubiquitinated and degraded by the UPP. Interestingly, the UPP enzymes and components of both the 19S and 20S proteasomes are recruited to NHR target gene promoters suggesting that the UPP could be involved in NHR transcription regulation at multiple steps. In recent years, it has been demonstrated that the role of ubiquitin can be expanded well beyond its function of acting as a death-tag for the degradation of proteins by the 26S proteasome. Keeping in mind the involvement of the UPP in a variety of cellular processes, its deregulation or malfunction has been associated with a number of human diseases including cancers. Targeting the UPP as a potential for drug discovery in the treatment of cancer and neurodegenerative disorders is just beginning. In this chapter, we will discuss the probable role of the UPP in NHR regulated gene transcription and also the possibility of targeting the UPP for drug discovery for the treatment of endocrine cancers like breast and prostate cancers.

AB - The ubiquitin-proteasome pathway (UPP) constitutes the major pathway for degradation of nuclear and cytoplasmic proteins in the eukaryotic cell. The role of the UPP in cell cycle progression and signal transduction pathways is well known, but its role in nuclear hormone receptor (NHR) functions is a surprise to many scientists. The involvement of a number of UPP components in NHR-mediated transcription suggested a possible link between these two diverse pathways. Both NHRs and their coregulators (coactivators and corepressors) are ubiquitinated and degraded by the UPP. Interestingly, the UPP enzymes and components of both the 19S and 20S proteasomes are recruited to NHR target gene promoters suggesting that the UPP could be involved in NHR transcription regulation at multiple steps. In recent years, it has been demonstrated that the role of ubiquitin can be expanded well beyond its function of acting as a death-tag for the degradation of proteins by the 26S proteasome. Keeping in mind the involvement of the UPP in a variety of cellular processes, its deregulation or malfunction has been associated with a number of human diseases including cancers. Targeting the UPP as a potential for drug discovery in the treatment of cancer and neurodegenerative disorders is just beginning. In this chapter, we will discuss the probable role of the UPP in NHR regulated gene transcription and also the possibility of targeting the UPP for drug discovery for the treatment of endocrine cancers like breast and prostate cancers.

UR - http://www.scopus.com/inward/record.url?scp=84969611116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969611116&partnerID=8YFLogxK

U2 - 10.1142/9789812819178_0003

DO - 10.1142/9789812819178_0003

M3 - Chapter

AN - SCOPUS:84969611116

SN - 9789812819178

SN - 9812705368

SN - 9789812705365

SP - 176

EP - 207

BT - NR Coregulators and Human Diseases

PB - World Scientific Publishing Co.

ER -